An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort descending
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy 2.00 12/18/2020 - 12:00am to 12/18/2021 - 12:00am
Recorded Presentation from the New NCCN Guidelines for Pediatric Cancers: Key Considerations for the Management of Pediatric Hodgkin Lymphoma 1.00 12/23/2020 - 12:00am to 12/23/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Central Nervous System Cancers 1.00 12/23/2020 - 12:00am to 12/23/2021 - 12:00am
BCOP Test - Emerging Strategies in the Treatment of Venous Thromboembolism 12/23/2020 - 2:30pm to 12/23/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism 1.00 12/24/2020 - 12:00am to 12/23/2021 - 12:00am
NCCN Guidelines® Insights - Acute Myeloid Leukemia, Version 2.2021 1.00 01/10/2021 - 12:00am to 01/10/2022 - 12:00am
Recorded Presentation from the New NCCN Guidelines for Pediatric Cancers: Advancements in the Management of Pediatric Acute Lymphoblastic Leukemia 1.00 01/27/2021 - 12:00am to 01/27/2022 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer 1.00 01/28/2021 - 12:00am to 01/28/2022 - 12:00am
NCCN Pharmacy Updates: Novel Agents for the Treatment of Relapsed/Refractory Multiple Myeloma 1.00 01/29/2021 - 12:00am to 08/01/2021 - 12:00am
NCCN Pharmacy Updates: Emerging Strategies for Pediatric Hodgkin Lymphoma Treatment 1.00 02/08/2021 - 12:00am to 09/05/2021 - 12:00am
Recorded Presentation from the New NCCN Guidelines for Pediatric Cancers: Management of Pediatric Aggressive Mature B-Cell Lymphoma 1.00 02/09/2021 - 12:00am to 02/09/2022 - 12:00am
NCCN Guidelines® Insights - Prostate Cancer, Version 1.2021 1.00 02/10/2021 - 12:00am to 02/10/2022 - 12:00am
BCOP Test - New Agents for Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors 02/15/2021 - 4:00pm to 02/15/2022 - 12:00am
HER2-Positive Breast Cancer: A Guide Through An Evolving Treatment Landscape 1.50 02/25/2021 - 12:00am to 02/25/2022 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: New Agents for Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors 1.00 02/25/2021 - 12:00am to 02/15/2022 - 12:00am

Pages